A Phase I/II Multicenter Open-label Dose Escalation Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy
Phase of Trial: Phase I/II
Latest Information Update: 17 Apr 2017
At a glance
- Drugs Cerebroside-sulfatase (Primary)
- Indications Metachromatic leukodystrophy
- Focus Adverse reactions; First in man
- Acronyms IDEAMLD
- Sponsors Shire
- 31 Jan 2017 Status changed from active, no longer recruiting to completed.
- 13 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Oct 2015 Status changed from active, no longer recruiting to recruiting, as reported by ClinicalTrials.gov.